A specific low-dose multislice CT protocol can provide clinically useful images of the wrists, taking the trade-off between image quality and low radiation exposure up a notch.
A specific low-dose multislice CT protocol can provide clinically useful images of the wrists, taking the trade-off between image quality and low radiation exposure up a notch.
Using cadaver wrist specimens, Dr. Harald Bonel and colleagues at the University of Berne Hospital in Switzerland found one protocol that provided superior image resolution at the expense of bearable artifacts.
The best acquisition and reconstruction protocol featured four-slice scanning, 0.5 mm to 1-mm slice thickness, 2 mm x 0.5-mm collimation, 0.75-sec rotation time, 80 kVp, 100 mAs, and 1.5 or lower pitch.
Even though 3D reconstructions provide a handy presentation format, most imaging workups of the wrists should rely on MRI for characterization of soft tissues, according to the study published in the September American Journal of Roentgenology.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.